|
3PQY
Crystal Structure of 6218 TCR in complex with the H2Db-PA224
Deposited 2010-11-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
107–249(143 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;10-14% PEG 3350, 0.2M KCN, 0.1M Bis Tris Propane pH 6.8, 5% glycerol, vapor diffusion, hanging drop, temperature 277K
|
Resolution 3.19 Å
R-free 0.316
|
|
3PQY
Crystal Structure of 6218 TCR in complex with the H2Db-PA224
Deposited 2010-11-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain J
107–249(143 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;10-14% PEG 3350, 0.2M KCN, 0.1M Bis Tris Propane pH 6.8, 5% glycerol, vapor diffusion, hanging drop, temperature 277K
|
Resolution 3.19 Å
R-free 0.316
|
|
3PQY
Crystal Structure of 6218 TCR in complex with the H2Db-PA224
Deposited 2010-11-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain O
107–249(143 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;10-14% PEG 3350, 0.2M KCN, 0.1M Bis Tris Propane pH 6.8, 5% glycerol, vapor diffusion, hanging drop, temperature 277K
|
Resolution 3.19 Å
R-free 0.316
|
|
3PQY
Crystal Structure of 6218 TCR in complex with the H2Db-PA224
Deposited 2010-11-28
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain T
107–249(143 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;277 K;10-14% PEG 3350, 0.2M KCN, 0.1M Bis Tris Propane pH 6.8, 5% glycerol, vapor diffusion, hanging drop, temperature 277K
|
Resolution 3.19 Å
R-free 0.316
|
|
4MNH
Structure of the DP10.7 TCR
Deposited 2013-09-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
120–259(140 aa)
Fragment:DP10.7 TCR gamma variable domain fused with human TCR beta constant domain
|
Mutation:S173C, C191A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;292 K;0.1 M Tris pH 8.5, 20% PEG 10k, VAPOR DIFFUSION, SITTING DROP, temperature 292K
|
Resolution 3.30 Å
R-free 0.285
|
|
4MNH
Structure of the DP10.7 TCR
Deposited 2013-09-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
120–259(140 aa)
Fragment:DP10.7 TCR gamma variable domain fused with human TCR beta constant domain
|
Mutation:S173C, C191A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;292 K;0.1 M Tris pH 8.5, 20% PEG 10k, VAPOR DIFFUSION, SITTING DROP, temperature 292K
|
Resolution 3.30 Å
R-free 0.285
|
|
5BRZ
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1
Deposited 2015-06-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
108–248(141 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.2M ammonium chloride, 0.1M HEPES pH7, 15% PEG 8000
|
Resolution 2.62 Å
R-free 0.268
|
|
5BS0
MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1
Deposited 2015-06-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
108–249(142 aa)
|
Not recorded
|
GOL GLYCEROL × 1
SO4 SULFATE ION × 11
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;0.2M Ammonium Chloride, 0.1M MES, 20% PEG 4000
|
Resolution 2.40 Å
R-free 0.262
|
|
5MEN
Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor
Deposited 2016-11-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
125–249(125 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 5
GOL GLYCEROL × 1
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M ammonium sulphate, 0.1M HEPES pH7, 20% PEG 8000
|
Resolution 2.81 Å
R-free 0.272
|
|
5WLG
Crystal Structure of H-2Db with the GAP501 peptide (SQL)
Deposited 2017-07-26
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
120–249(130 aa)
|
Not recorded
|
NA SODIUM ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.2;277 K;18%PEG3350, 2% ethylen glycol, 0.2M CaCl2, 0.1M HEPES pH 7.2
|
Resolution 2.10 Å
R-free 0.249
|
|
5WLG
Crystal Structure of H-2Db with the GAP501 peptide (SQL)
Deposited 2017-07-26
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain J
120–249(130 aa)
|
Not recorded
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.2;277 K;18%PEG3350, 2% ethylen glycol, 0.2M CaCl2, 0.1M HEPES pH 7.2
|
Resolution 2.10 Å
R-free 0.249
|
|
6BJ2
TCR589 in complex with HIV(Pol448-456)/HLA-B35
Deposited 2017-11-03
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
120–249(130 aa)
|
Not recorded
|
ZN ZINC ION × 3
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;295 K;0.1 M Tris, pH 8.0, 20% PEG3350, 0.002 M zinc chloride
|
Resolution 3.35 Å
R-free 0.276
|
|
6BJ3
TCR55 in complex with HIV(Pol448-456)/HLA-B35
Deposited 2017-11-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain H
107–249(143 aa)
|
Mutation:A187C
|
EDO 1,2-ETHANEDIOL × 3
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;295 K;PEG4000, 0.1 M sodium cacodylate, pH 6.0, 0.2 M ammonium sulfate
|
Resolution 1.90 Å
R-free 0.216
|
|
6BJ8
TCR55 in complex with Pep20/HLA-B35
Deposited 2017-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain H
107–249(143 aa)
|
Mutation:A187C
|
GOL GLYCEROL × 27
PO4 PHOSPHATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;295 K;0.04 M potassium phosphate monobasic, 16% w/v PEG8000, 20% v/v glycerol
|
Resolution 1.75 Å
R-free 0.183
|
|
6CW6
Structure of alpha-GC[8,18] bound by CD1d and in complex with the Va14Vb8.2 TCR
Deposited 2018-03-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
138–248(111 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
PBS (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA-D-GALACTOPYRANOSYL)OXY]-2-AMINO-OCTADECANE-3,4-DIOL × 1
PLM PALMITIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;295 K;8% Tacsimate pH 4.0
20% PEG 3350
|
Resolution 2.85 Å
R-free 0.250
|
|
6D78
The complex between high-affinity TCR DMF5(alpha-D26Y,beta-L98W) and human Class I MHC HLA-A2 with the bound MART-1(27-35)peptide
Deposited 2018-04-24
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
125–249(125 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;0.1 M Tris, 12% PEG6000, 0.2 M magnesium chloride
|
Resolution 2.35 Å
R-free 0.255
|
|
6DKP
The complex among DMF5(alpha-D26Y, alpha-Y50A,beta-L98W) TCR, human Class I MHC HLA-A2 and MART-1(26-35)(A27L) peptide
Deposited 2018-05-30
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
120–249(130 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;12% Peg 3350, 250mM MgCl2, 0.1M HEPES
|
Resolution 2.97 Å
R-free 0.286
|
|
6PY2
HLA-TCR complex
Deposited 2019-07-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
120–249(130 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MES, pH 6.5, 5% v/v MPD, 15% w/v PEG6000
|
Resolution 2.83 Å
R-free 0.244
|
|
6Q3S
Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide
Deposited 2018-12-04
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
123–249(127 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M ammonium acetate; 0.1 M bis-tris pH 5.5, 17 %(w/v) PEG 10.000
|
Resolution 2.50 Å
R-free 0.273
|
|
6R2L
NYBR1-A2-SLSKILDTV
Deposited 2019-03-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
107–249(143 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 1
EDO 1,2-ETHANEDIOL × 2
GOL GLYCEROL × 3
SO4 SULFATE ION × 8
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;0.2 M NaCl, 0.1 M MES, 20% PEG 6000, pH 6.0 . Condition B07 from Molecular Dimensions PACT premier HT-96/FX-96, MD1-36
|
Resolution 2.30 Å
R-free 0.265
|
|
6U07
Computational Stabilization of T Cell Receptor Constant Domains
Deposited 2019-08-13
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
120–249(130 aa)
|
Not recorded
|
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;23% PEG 4K, 300 mM magnesium sulfate, 10% glycerol
|
Resolution 1.76 Å
R-free 0.226
|
|
6V80
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
Deposited 2019-12-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
6–249(244 aa)
|
Not recorded
|
AGH N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;21 % (v/v) PEG 3350, 0.2 M tri-sodium citrate, 3% (v/v) D-(+)-trehalose dehydrate
|
Resolution 3.53 Å
R-free 0.254
|
|
6V80
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
Deposited 2019-12-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain I
6–249(244 aa)
|
Not recorded
|
AGH N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;21 % (v/v) PEG 3350, 0.2 M tri-sodium citrate, 3% (v/v) D-(+)-trehalose dehydrate
|
Resolution 3.53 Å
R-free 0.254
|
|
7M72
MHC-like protein complex structure
Deposited 2021-03-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
120–249(130 aa)
Fragment:murine variable domain,human constant domain
|
Not recorded
|
QOD (3R)-N-[(2S,3R)-1-(alpha-D-galactopyranosyloxy)-3-hydroxy-15-methylhexadecan-2-yl]-3-hydroxyheptadecanamide × 1
HP6 HEPTANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;277 K;18-20% PEG 3350, 8% Tacsimate pH 5.0
|
Resolution 2.40 Å
R-free 0.227
|
|
7N4K
6218 TCR in complex with H2-Db PA 224
Deposited 2021-06-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
107–249(143 aa)
|
Not recorded
|
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;20% PEG3350, 0.2 M NaF, 0.05 M NaForm, 1% 1,5-Diaminopentane dihydrochloride
|
Resolution 1.85 Å
R-free 0.214
|
|
7N5C
6218 TCR in complex with H2Db PA with an engineered TCR-pMHC disulfide bond
Deposited 2021-06-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
107–249(143 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;20% PEG3350, 0.2M NaF, 0.05M NaForm, 1% 1,5-Diaminopentane dihydrochloride
|
Resolution 1.87 Å
R-free 0.233
|
|
7N5P
6218 TCR in complex with H2-Db PA224-233 with a cysteine mutant
Deposited 2021-06-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
107–249(143 aa)
|
Not recorded
|
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;20% PEG3350, 0.2M NaF, 0.05M NaForm, 1% 1,5-Diaminopentane dihydrochloride
|
Resolution 2.09 Å
R-free 0.236
|
|
7NDQ
Gag:02 TCR in complex with HLA-E.
Deposited 2021-02-02
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain EEE
120–249(130 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;23.2% (w/v) PEG 1500, 93 mM MMT pH 9.0
|
Resolution 2.55 Å
R-free 0.296
|
|
7NDU
Gag:02 TCR in complex with HLA-E featuring a non-natural amino acid
Deposited 2021-02-02
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain EEE
120–249(130 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;22.3% (w/v) PEG 1500, 89 mM MMT pH 9.0
|
Resolution 2.90 Å
R-free 0.301
|